In adrenocortical carcinoma, chemerin overexpression decreased cell proliferation and invasion in vitro and tumor growth in vivo by promoting β-catenin phosphorylation and degradation and inhibiting the phosphorylation of p38 MAPK [14]. The gene discussed is RARRES2; the disease is adrenal cortex carcinoma.